Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer

Robert S. Svatek, Mark Munsell, Jordan M. Kincaid, Paul Hegarty, Joel W. Slaton, J. Erik Busby, Kris E. Gaston, Philippe E. Spiess, Lance C. Pagliaro, Pheroze Tamboli, Curtis A. Pettaway

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Purpose: We assessed the value of lymph node density for predicting disease specific survival after lymphadenectomy for penile cancer. Materials and Methods: Data were collected retrospectively in 75 and prospectively in 88 consecutive patients with squamous cell carcinoma of the penis treated at M. D. Anderson Cancer Center between 1979 and 2007. We identified 45 patients with penile cancer and nodal metastasis who underwent lymphadenectomy with curative intent. Lymph node density was analyzed as a categorical variable by grouping patients into 2 or 3 categories based on equal percents. We explored the prognostic value of lymph node density for predicting disease specific survival in this cohort. Results: Median followup was 23.7 months in all patients. By the time of analysis 22 patients had died, including 18 (82%) of penile cancer and 4 (18%) of other causes. Median lymph node density in patients alive or dead of other causes was 3.4% (IQR 2.9-5.9) compared to 43.3% (IQR 15.6-80) in those dead of disease (p <0.001). Median lymph node density in all patients was 6.7%. Estimated 5-year disease specific survival in patients with lymph node density 6.7% or less was significantly better than that in patients with lymph node density greater than 6.7% (91.2%, 95% CI 53.9-98.8 vs 23.3%, 95% CI 7.0-45.1, p <0.001). In models comparing lymph node density to known prognostic features lymph node density remained statistically significant, while the other factors were no longer statistically associated with disease specific survival. Conclusions: Lymph node density proved to be a significantly better prognosticator of disease specific survival than the current TNM nodal staging system in patients with penile cancer and nodal involvement. Further independent validation is required to determine the clinical usefulness of lymph node density in this patient population.

Original languageEnglish (US)
Pages (from-to)2721-2727
Number of pages7
JournalJournal of Urology
Volume182
Issue number6
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Penile Neoplasms
Lymph Nodes
Survival
Lymph Node Excision
Neoplasm Staging
Penis
Squamous Cell Carcinoma

Keywords

  • lymph node excision
  • lymph nodes
  • penile neoplasms
  • penis
  • prognosis

ASJC Scopus subject areas

  • Urology

Cite this

Svatek, R. S., Munsell, M., Kincaid, J. M., Hegarty, P., Slaton, J. W., Busby, J. E., ... Pettaway, C. A. (2009). Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer. Journal of Urology, 182(6), 2721-2727. https://doi.org/10.1016/j.juro.2009.08.029

Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer. / Svatek, Robert S.; Munsell, Mark; Kincaid, Jordan M.; Hegarty, Paul; Slaton, Joel W.; Busby, J. Erik; Gaston, Kris E.; Spiess, Philippe E.; Pagliaro, Lance C.; Tamboli, Pheroze; Pettaway, Curtis A.

In: Journal of Urology, Vol. 182, No. 6, 12.2009, p. 2721-2727.

Research output: Contribution to journalArticle

Svatek, RS, Munsell, M, Kincaid, JM, Hegarty, P, Slaton, JW, Busby, JE, Gaston, KE, Spiess, PE, Pagliaro, LC, Tamboli, P & Pettaway, CA 2009, 'Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer', Journal of Urology, vol. 182, no. 6, pp. 2721-2727. https://doi.org/10.1016/j.juro.2009.08.029
Svatek, Robert S. ; Munsell, Mark ; Kincaid, Jordan M. ; Hegarty, Paul ; Slaton, Joel W. ; Busby, J. Erik ; Gaston, Kris E. ; Spiess, Philippe E. ; Pagliaro, Lance C. ; Tamboli, Pheroze ; Pettaway, Curtis A. / Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer. In: Journal of Urology. 2009 ; Vol. 182, No. 6. pp. 2721-2727.
@article{d9fd9436971040738422e3a76733a324,
title = "Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer",
abstract = "Purpose: We assessed the value of lymph node density for predicting disease specific survival after lymphadenectomy for penile cancer. Materials and Methods: Data were collected retrospectively in 75 and prospectively in 88 consecutive patients with squamous cell carcinoma of the penis treated at M. D. Anderson Cancer Center between 1979 and 2007. We identified 45 patients with penile cancer and nodal metastasis who underwent lymphadenectomy with curative intent. Lymph node density was analyzed as a categorical variable by grouping patients into 2 or 3 categories based on equal percents. We explored the prognostic value of lymph node density for predicting disease specific survival in this cohort. Results: Median followup was 23.7 months in all patients. By the time of analysis 22 patients had died, including 18 (82{\%}) of penile cancer and 4 (18{\%}) of other causes. Median lymph node density in patients alive or dead of other causes was 3.4{\%} (IQR 2.9-5.9) compared to 43.3{\%} (IQR 15.6-80) in those dead of disease (p <0.001). Median lymph node density in all patients was 6.7{\%}. Estimated 5-year disease specific survival in patients with lymph node density 6.7{\%} or less was significantly better than that in patients with lymph node density greater than 6.7{\%} (91.2{\%}, 95{\%} CI 53.9-98.8 vs 23.3{\%}, 95{\%} CI 7.0-45.1, p <0.001). In models comparing lymph node density to known prognostic features lymph node density remained statistically significant, while the other factors were no longer statistically associated with disease specific survival. Conclusions: Lymph node density proved to be a significantly better prognosticator of disease specific survival than the current TNM nodal staging system in patients with penile cancer and nodal involvement. Further independent validation is required to determine the clinical usefulness of lymph node density in this patient population.",
keywords = "lymph node excision, lymph nodes, penile neoplasms, penis, prognosis",
author = "Svatek, {Robert S.} and Mark Munsell and Kincaid, {Jordan M.} and Paul Hegarty and Slaton, {Joel W.} and Busby, {J. Erik} and Gaston, {Kris E.} and Spiess, {Philippe E.} and Pagliaro, {Lance C.} and Pheroze Tamboli and Pettaway, {Curtis A.}",
year = "2009",
month = "12",
doi = "10.1016/j.juro.2009.08.029",
language = "English (US)",
volume = "182",
pages = "2721--2727",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer

AU - Svatek, Robert S.

AU - Munsell, Mark

AU - Kincaid, Jordan M.

AU - Hegarty, Paul

AU - Slaton, Joel W.

AU - Busby, J. Erik

AU - Gaston, Kris E.

AU - Spiess, Philippe E.

AU - Pagliaro, Lance C.

AU - Tamboli, Pheroze

AU - Pettaway, Curtis A.

PY - 2009/12

Y1 - 2009/12

N2 - Purpose: We assessed the value of lymph node density for predicting disease specific survival after lymphadenectomy for penile cancer. Materials and Methods: Data were collected retrospectively in 75 and prospectively in 88 consecutive patients with squamous cell carcinoma of the penis treated at M. D. Anderson Cancer Center between 1979 and 2007. We identified 45 patients with penile cancer and nodal metastasis who underwent lymphadenectomy with curative intent. Lymph node density was analyzed as a categorical variable by grouping patients into 2 or 3 categories based on equal percents. We explored the prognostic value of lymph node density for predicting disease specific survival in this cohort. Results: Median followup was 23.7 months in all patients. By the time of analysis 22 patients had died, including 18 (82%) of penile cancer and 4 (18%) of other causes. Median lymph node density in patients alive or dead of other causes was 3.4% (IQR 2.9-5.9) compared to 43.3% (IQR 15.6-80) in those dead of disease (p <0.001). Median lymph node density in all patients was 6.7%. Estimated 5-year disease specific survival in patients with lymph node density 6.7% or less was significantly better than that in patients with lymph node density greater than 6.7% (91.2%, 95% CI 53.9-98.8 vs 23.3%, 95% CI 7.0-45.1, p <0.001). In models comparing lymph node density to known prognostic features lymph node density remained statistically significant, while the other factors were no longer statistically associated with disease specific survival. Conclusions: Lymph node density proved to be a significantly better prognosticator of disease specific survival than the current TNM nodal staging system in patients with penile cancer and nodal involvement. Further independent validation is required to determine the clinical usefulness of lymph node density in this patient population.

AB - Purpose: We assessed the value of lymph node density for predicting disease specific survival after lymphadenectomy for penile cancer. Materials and Methods: Data were collected retrospectively in 75 and prospectively in 88 consecutive patients with squamous cell carcinoma of the penis treated at M. D. Anderson Cancer Center between 1979 and 2007. We identified 45 patients with penile cancer and nodal metastasis who underwent lymphadenectomy with curative intent. Lymph node density was analyzed as a categorical variable by grouping patients into 2 or 3 categories based on equal percents. We explored the prognostic value of lymph node density for predicting disease specific survival in this cohort. Results: Median followup was 23.7 months in all patients. By the time of analysis 22 patients had died, including 18 (82%) of penile cancer and 4 (18%) of other causes. Median lymph node density in patients alive or dead of other causes was 3.4% (IQR 2.9-5.9) compared to 43.3% (IQR 15.6-80) in those dead of disease (p <0.001). Median lymph node density in all patients was 6.7%. Estimated 5-year disease specific survival in patients with lymph node density 6.7% or less was significantly better than that in patients with lymph node density greater than 6.7% (91.2%, 95% CI 53.9-98.8 vs 23.3%, 95% CI 7.0-45.1, p <0.001). In models comparing lymph node density to known prognostic features lymph node density remained statistically significant, while the other factors were no longer statistically associated with disease specific survival. Conclusions: Lymph node density proved to be a significantly better prognosticator of disease specific survival than the current TNM nodal staging system in patients with penile cancer and nodal involvement. Further independent validation is required to determine the clinical usefulness of lymph node density in this patient population.

KW - lymph node excision

KW - lymph nodes

KW - penile neoplasms

KW - penis

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=72149096793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72149096793&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2009.08.029

DO - 10.1016/j.juro.2009.08.029

M3 - Article

C2 - 19837433

AN - SCOPUS:72149096793

VL - 182

SP - 2721

EP - 2727

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -